These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 27829331)
1. QSAR Studies, Synthesis and Antibacterial Assessment of New Inhibitors Against Multidrug-Resistant Mycobacterium tuberculosis. Kovalishyn V; Brovarets V; Blagodatnyi V; Kopernyk I; Hodyna D; Chumachenko S; Shablykin O; Kozachenko O; Vovk M; Barus M; Bratenko M; Metelytsia L Curr Drug Discov Technol; 2017; 14(1):25-38. PubMed ID: 27829331 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds. Ventura C; Latino DA; Martins F Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship. Tomioka H Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755 [TBL] [Abstract][Full Text] [Related]
4. Hybrid Design of Isonicotinic Acid Hydrazide Derivatives: Machine Learning Studies, Synthesis and Biological Evaluation of their Antituberculosis Activity. Kovalishyn V; Hodyna D; Sinenko VO; Blagodatny V; Semenyuta I; Slivchuk SR; Brovarets V; Poda G; Metelytsia L Curr Drug Discov Technol; 2020; 17(3):365-375. PubMed ID: 30973110 [TBL] [Abstract][Full Text] [Related]
5. QSAR based design of new antitubercular compounds: improved isoniazid derivatives against multidrug-resistant TB. Martins F; Ventura C; Santos S; Viveiros M Curr Pharm Des; 2014; 20(27):4427-54. PubMed ID: 24245762 [TBL] [Abstract][Full Text] [Related]
6. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain. Raja S; Prakash CR Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents. Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538 [TBL] [Abstract][Full Text] [Related]
9. DFT based QSAR/QSPR models in the development of novel anti-tuberculosis drugs targeting Mycobacterium tuberculosis. Rajkhowa S; Deka RC Curr Pharm Des; 2014; 20(27):4455-73. PubMed ID: 24245759 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity. Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065 [TBL] [Abstract][Full Text] [Related]
11. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains. da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
14. QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity. Gomes MN; Braga RC; Grzelak EM; Neves BJ; Muratov E; Ma R; Klein LL; Cho S; Oliveira GR; Franzblau SG; Andrade CH Eur J Med Chem; 2017 Sep; 137():126-138. PubMed ID: 28582669 [TBL] [Abstract][Full Text] [Related]
15. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis. Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748 [TBL] [Abstract][Full Text] [Related]
16. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis. Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620 [TBL] [Abstract][Full Text] [Related]
18. ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines. Saxena AK; Alam M Curr Top Med Chem; 2020; 20(29):2723-2734. PubMed ID: 32885753 [TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Pakistan 2010-2014: Implications for disease control. Jabeen K; Shakoor S; Malik F; Hasan R Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():47-8. PubMed ID: 27128617 [TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]